logologo
CtrlK
logologo

Home

Watchlist

Market Screener

By Industry
Top Performing
Top Trading

Portfolio

News

News Feed
SEC Filings

Strategy Lab

Hedgefund
Community

Stocks

/

EXOZ

eXoZymes Inc

EXOZ

NASDAQ

Biotechnology

$8.03

USD

+$0.63 (+8.51%)

Last close

Market Cap:

$67.13M

Volume:

8.5K

Price (USD)
Key Statistics

Previous Close

$7.40

Day Range

$7.21 - $8.03

52 Week Range

$6.33 - $18.40

Average Volume (10 Days)

10K

P/E Ratio

0.00

Dividend Yield

0.00%

About This Company

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

CEO

Mr. Michael Heltzen

Headquaters

Monrovia California, CALIFORNIA, US

Founded

2024

Employees

32

Similar Stocks

XBIT

XBiotech Inc

$2.33

0.0%

GANX

Gain Therapeutics Inc

$1.75

+1.7%

GOSS

Gossamer Bio Inc

$0.1600

-5.0%

ACRV

Acrivon Therapeutics Inc

$1.68

+6.3%

BYSI

Beyondspring Inc

$1.69

+5.6%

SERA

Sera Prognostics Inc

$1.80

0.0%

ELTX

Elicio Therapeutics Inc

$4.00

+6.7%

MCRB

Seres Therapeutics Inc

$7.08

+3.4%